Brief: Invivo Therapeutics Says Received Notice From Nasdaq Of Failure To Satisfy A Continued Listing Rule
21/05/2021 21:48
May 21 (Reuters) - InVivo Therapeutics Holdings Corp
NVIV.O :
* INVIVO THERAPEUTICS - ON MAY 19, RECEIVED NOTICE FROM
NASDAQ OF
FAILURE TO SATISFY A CONTINUED LISTING RULE
Source: (https://bit.ly/3vfphcY)
Further company coverage: NVIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InVivo Therapeutics Holdings
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
InVivo Therapeutics falls on filing for Chapter 11 bankruptcy
Brief: InVivo Therapeutics Holdings Received Notice Of Delisting Or Failure To Satisfy Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR